科研
教育
解决方案
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
PL - Polish
RU - Russian
Clinical Center of Biotherapy at Zhongshan Hospital
Yunyu Mao has not added Biography.
If you are Yunyu Mao and would like to personalize this page please email our Author Liaison for assistance.
Current status and future development of anti-HIV chimeric antigen receptor T-cell therapy.
Immunotherapy Feb, 2021 | Pubmed ID: 33225803
Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing.
Biomarker research Oct, 2020 | Pubmed ID: 33292642
PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo.
Biomarker research Nov, 2020 | Pubmed ID: 33292688
Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study.
Cell discovery May, 2024 | Pubmed ID: 38740803
Fudan University
Ying Xue*,1,
Yunyu Mao*,2,
Qibin Liao3,
Chen Zhao4,
Xiaoyan Zhang1,2,4,
Jianqing Xu1,2,4
1Institutes of Biomedical Sciences, Fudan University,
2Clinical Center of Biotherapy at Zhongshan Hospital, Fudan University,
3Department of Oncology and Bio-therapeutic Center, Shenzhen Third People's Hospital, Southern University of Science and Technology,
4Shanghai Public Health Clinical Center, Fudan University
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2025 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。
